Get Free Delivery With No Minimum Order

MEVA 135/MG FC TAB 30/FC TAB
- Sku : I-003826
Key features
Meva 135mg Film-Coated Tablet 30 Tablets is a film-coated tablet formulation containing mebeverine hydrochloride 135 mg per tablet. It acts as a musculotropic antispasmodic, directly relaxing gastrointestinal smooth muscle to relieve spasms while largely preserving normal intestinal motility; the exact mechanism is not fully established and may involve modulation of ion channels and reduced smooth‑muscle excitability. It is indicated for the symptomatic treatment of irritable bowel syndrome and other functional gastrointestinal disorders characterized by smooth‑muscle spasm causing abdominal pain and cramps. Available as film‑coated tablets in a pack of 30; prescription only.- Brand: MEVA
- Active Ingredient: MEBEVERINE HYDROCHLORIDE 135mg
- Strength: 135mg
- Dosage Form: Film-coated tablet
- Pack Size: 30 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Antispasmodics
- Drug Class: Antispasmodic (musculotropic smooth‑muscle relaxant) for gastrointestinal tract (ATC A03AA04).
- Manufacturer: Jamjoom Pharmaceuticals Factory Company
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1506222203
- Shelf Life: 36 months
- Storage: store below 30°c
- Gi Condition: IBS
Indications
Approved Uses
Symptomatic treatment of irritable bowel syndrome (IBS) and other functional gastrointestinal disorders where smooth‑muscle spasm causes abdominal pain/cramps (often described as spastic/irritable colon).
Dosage & Administration
Dosing by Condition
IBS/functional GI spasm: 135 mg orally three times daily, preferably about 20 minutes before meals.
Initial Dose
One 135mg tablet three times daily.
Maintenance Dose
One 135mg tablet three times daily; dosage may be gradually reduced after several weeks if the desired effect is achieved.
Maximum Dose
405 mg/day (135 mg three times daily)
How to Take
Swallow the 135 mg film‑coated tablet whole with water; do not chew or crush. Preferably take about 20 minutes before meals.
Side Effects
Common Side Effects
Generally uncommon; most reported are hypersensitivity reactions (rash, urticaria, pruritus; rarely angioedema/anaphylaxis) and occasional dizziness or headache; gastrointestinal upset can occur but is not prominent.
Side Effect Frequency
Adverse effects are generally uncommon; most reported events are hypersensitivity reactions (e.g., rash, urticaria, angioedema, anaphylaxis) with GI or CNS effects (e.g., nausea, dyspepsia, headache, dizziness) reported but without consistent ‘common (1-10%)’ frequency assignment.
Safety & Warnings
Contraindications
Hypersensitivity to mebeverine hydrochloride or any excipient; paralytic ileus
Drug Interactions
Drug Interactions
No known clinically significant drug interactions
Interaction Severity
No clinically significant drug interactions are well documented/none known.
Food Interaction
Take 20 minutes before meals.
Special Populations
Elderly
Standard adult dosing.
Storage & Patient Advice
Patient Counseling
Take 135 mg three times daily, preferably ~20 minutes before meals; swallow whole with water and do not chew/crush. Do not exceed the prescribed dose; if a dose is missed, do not double. Seek medical advice if symptoms persist/worsen (e.g., no improvement after ~2 weeks) or if alarm features occur (rectal bleeding, weight loss, fever, persistent vomiting) or signs of allergy/angioedema develop.
Pharmacology
Mechanism of Action
Musculotropic antispasmodic that directly relaxes gastrointestinal smooth muscle, relieving spasm without significantly affecting normal motility; the exact mechanism is not fully established (proposed effects include modulation of ion channels and reduced smooth‑muscle excitability).
Protein Binding
Protein binding: not reliably established/commonly reported in major labeling; treat as unknown for clinical decision-making.
Product Information
Available Dosage Forms
For this product (MEVA): film‑coated tablet (oral). Other mebeverine products may exist as modified‑release capsules, but that is not this registered product.
Composition per Dose
Each film-coated tablet: 135mg mebeverine hydrochloride.
Generic Availability
Yes
OTC Alternatives
No OTC alternative
Gi Condition
IBS
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)





